UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Journal of Clinical Microbiology, 2013-08, Vol.51 (8), p.2571-2581

2013

Link zum Volltext

Verfügbarkeit prüfen

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Journal of Clinical Microbiology, 2013-01, Vol.51 (1), p.117-124

2013

Link zum Volltext

Verfügbarkeit prüfen

Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America

Microbiology spectrum, 2023-02, Vol.11 (1), p.e0467322-e0467322

2023

Link zum Volltext

Verfügbarkeit prüfen

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.577-580

2014

Link zum Volltext

Verfügbarkeit prüfen

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2655-2659

2010

Link zum Volltext

Verfügbarkeit prüfen

CEM-101 Activity against Gram-Positive Organisms

Antimicrobial Agents and Chemotherapy, 2010-05, Vol.54 (5), p.2182-2187

2010

Link zum Volltext

Verfügbarkeit prüfen

Oritavancin Activity against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci with Molecularly Characterized Glycopeptide Resistance Genes Recovered from Bacteremic Patients, 2009-2010

Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1639-1642

2012

Link zum Volltext

Verfügbarkeit prüfen

Retrospective Molecular Analysis of DIM-1 Metallo-β-Lactamase Discovered in Pseudomonas stutzeri from India in 2000

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.596-598

2014

Link zum Volltext

Verfügbarkeit prüfen

Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms

Journal of antimicrobial chemotherapy, 2018-12, Vol.73 (12), p.3346-3354

2018

Link zum Volltext

Verfügbarkeit prüfen

Characterization of β-Lactamase Content of Ceftazidime-Resistant Pathogens Recovered during the Pathogen-Directed Phase 3 REPRISE Trial for Ceftazidime-Avibactam: Correlation of Efficacy against β-Lactamase Producers

Antimicrobial agents and chemotherapy, 2019-06, Vol.63 (6)

2019

Link zum Volltext

Verfügbarkeit prüfen

Performance of Fusidic Acid (CEM-102) Susceptibility Testing Reagents: Broth Microdilution, Disk Diffusion, and Etest Methods as Applied to Staphylococcus aureus

Journal of Clinical Microbiology, 2010-03, Vol.48 (3), p.972-976

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7358-7366

2014

Link zum Volltext

Verfügbarkeit prüfen

Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States

Open forum infectious diseases, 2019-03, Vol.6 (Supplement_1), p.S69-S78

2019

Link zum Volltext

Verfügbarkeit prüfen

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007―09)

Journal of antimicrobial chemotherapy, 2011-06, Vol.66 (6), p.1409-1411

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets

International journal of antimicrobial agents, 2018-08, Vol.52 (2), p.287-292

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets

Antimicrobial agents and chemotherapy, 2017-06, Vol.61 (6)

2017

Link zum Volltext

Verfügbarkeit prüfen

Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme

Mycopathologia (1975), 2012-10, Vol.174 (4), p.259-271

2012

Link zum Volltext

Verfügbarkeit prüfen

Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype

mSphere, 2018-09, Vol.3 (5)

2018

Link zum Volltext

Verfügbarkeit prüfen

Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying bla KPC-2 Reveals a Heterogenous Population and Reversible Genotype

mSphere, 2018-09, Vol.3 (5)

2018

Link zum Volltext

Verfügbarkeit prüfen

Activity of Meropenem-Vaborbactam Against Enterobacteriaceae Isolates Carrying blaKPC Collected Worldwide

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S377-S377

2017

Link zum Volltext

Verfügbarkeit prüfen

Analyses of a Ceftazidime-Avibactam-Resistant italic toggle="yes">Citrobacter freundii /italic> Isolate Carrying italic toggle="yes">bla /italic>KPC-2 Reveals a Heterogenous Population and Reversible Genotype

mSphere, 2018-10, Vol.3 (5)

2018

Link zum Volltext

Verfügbarkeit prüfen

1444. Trends in Antimicrobial Non-susceptibility of PCV13-Type Streptococcus pneumoniae Pneumonia in Adults in the United States During 2009–2017

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S446-S447

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Delafloxacin and Microbiological Response Against Fluoroquinolone Susceptible and Non-Susceptible S. aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

Yearly Trends of Antimicrobial Non-susceptibility among Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients in the United States (2009–2015)

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S466-S467

2017

Link zum Volltext

Verfügbarkeit prüfen

Distributions and Annual Changes of Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients: Eight Years of US Surveillance (2009–2016)

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S468-S468

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Antimicrobial Agents And Chemotherapy
(10)
Open Forum Infectious Diseases
(9)
Journal Of Clinical Microbiology
(3)
Msphere
(3)
Journal Of Antimicrobial Chemotherapy
(2)
International Journal Of Antimicrobial Agents
(1)
Microbiology Spectrum
(1)
Mycopathologia
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs

Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

CEM-101 Activity against Gram-Positive Organisms

Oritavancin Activity against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci with Molecularly Characterized Glycopeptide Resistance Genes Recovered from Bacteremic Patients, 2009-2010

Retrospective Molecular Analysis of DIM-1 Metallo-β-Lactamase Discovered in Pseudomonas stutzeri from India in 2000

Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms

Characterization of β-Lactamase Content of Ceftazidime-Resistant Pathogens Recovered during the Pathogen-Directed Phase 3 REPRISE Trial for Ceftazidime-Avibactam: Correlation of Efficacy against β-Lactamase Producers

Performance of Fusidic Acid (CEM-102) Susceptibility Testing Reagents: Broth Microdilution, Disk Diffusion, and Etest Methods as Applied to Staphylococcus aureus

Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35

Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States

Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007―09)

Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets

Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets

Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme

Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying blaKPC-2 Reveals a Heterogenous Population and Reversible Genotype

Analyses of a Ceftazidime-Avibactam-Resistant Citrobacter freundii Isolate Carrying bla KPC-2 Reveals a Heterogenous Population and Reversible Genotype

Activity of Meropenem-Vaborbactam Against Enterobacteriaceae Isolates Carrying blaKPC Collected Worldwide

Analyses of a Ceftazidime-Avibactam-Resistant italic toggle="yes">Citrobacter freundii /italic> Isolate Carrying italic toggle="yes">bla /italic>KPC-2 Reveals a Heterogenous Population and Reversible Genotype

1444. Trends in Antimicrobial Non-susceptibility of PCV13-Type Streptococcus pneumoniae Pneumonia in Adults in the United States During 2009–2017

In Vitro Activity of Delafloxacin and Microbiological Response Against Fluoroquinolone Susceptible and Non-Susceptible S. aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

Yearly Trends of Antimicrobial Non-susceptibility among Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients in the United States (2009–2015)

Distributions and Annual Changes of Streptococcus pneumoniae Serotypes Causing Infections in Adult Patients: Eight Years of US Surveillance (2009–2016)

Suchergebnisse filtern